Literature DB >> 23151623

Thymosin β4 reduces senescence of endothelial progenitor cells via the PI3K/Akt/eNOS signal transduction pathway.

Juan Li1, Lu Yu, Yanbo Zhao, Guosheng Fu, Binquan Zhou.   

Abstract

We previously demonstrated that thymosin β4 (Tβ4) regulates a variety of endothelial progenitor cell (EPC) functions, including cell migration, proliferation, survival and angiogenesis. However, the effect of Tβ4 on the senescence of circulating EPCs remains unclear. In the present study, the effect of Tβ4 on EPC senescence and the signal transduction pathways involved in this process was investigated. Circulating EPCs isolated from healthy volunteers were cultured in the absence or presence of Tβ4 and various signal cascade inhibitors. Tβ4 inhibited EPC senescence in a concentration‑dependent manner. In addition, Tβ4 increased telomerase activity and expression of telomerase reverse transcriptase mRNA in EPCs. Tβ4 also regulated the expression of p21, p27 and cyclin D1. The effects of Tβ4 on EPC senescence were eliminated by the phosphoinositide 3'‑kinase (PI3K) inhibitor, wortmannin and the endothelial nitric oxide synthase inhibitor, L‑nitroarginine methyl ester hydrochloride (L‑NAME). In conclusion, the inhibitory effect on EPC senescence mediated by Tβ4 may be attributed, at least in part, to activation of the PI3K‑Akt‑eNOS signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23151623     DOI: 10.3892/mmr.2012.1180

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  8 in total

1.  Novel Contributors and Mechanisms of Cellular Senescence in Hypertension-Associated Premature Vascular Aging.

Authors:  Cameron G McCarthy; Camilla F Wenceslau; R Clinton Webb; Bina Joe
Journal:  Am J Hypertens       Date:  2019-07-17       Impact factor: 2.689

Review 2.  Cell Senescence and Central Regulators of Immune Response.

Authors:  Sergey M Lunin; Elena G Novoselova; Olga V Glushkova; Svetlana B Parfenyuk; Tatyana V Novoselova; Maxim O Khrenov
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

3.  Ascorbic acid inhibits senescence in mesenchymal stem cells through ROS and AKT/mTOR signaling.

Authors:  Mengkai Yang; Songsong Teng; Chunhui Ma; Yinxian Yu; Peilin Wang; Chengqing Yi
Journal:  Cytotechnology       Date:  2018-05-18       Impact factor: 2.058

4.  Coenzyme Q10 inhibits the aging of mesenchymal stem cells induced by D-galactose through Akt/mTOR signaling.

Authors:  Dayong Zhang; Bingxi Yan; Shanshan Yu; Chong Zhang; Baoming Wang; Yayan Wang; Junbo Wang; Zhanggen Yuan; Lihuang Zhang; Jianping Pan
Journal:  Oxid Med Cell Longev       Date:  2015-02-18       Impact factor: 6.543

5.  S-allylcysteine Improves Blood Flow Recovery and Prevents Ischemic Injury by Augmenting Neovasculogenesis.

Authors:  Jia-Ning Syu; Mei-Due Yang; Shu-Yao Tsai; En-Pei Isabel Chiang; Shao-Chih Chiu; Che-Yi Chao; Raymond L Rodriguez; Feng-Yao Tang
Journal:  Cell Transplant       Date:  2017-10       Impact factor: 4.064

6.  Thymosin β4 promotes glucose-impaired endothelial progenitor cell function via Akt/endothelial nitric oxide synthesis signaling pathway.

Authors:  Fuyu Qiu; Jiale Song; Xukun Bi; Meihui Wang; Yanbo Zhao; Guosheng Fu
Journal:  Exp Ther Med       Date:  2018-08-10       Impact factor: 2.447

7.  Bradykinin Protects Human Endothelial Progenitor Cells from High-Glucose-Induced Senescence through B2 Receptor-Mediated Activation of the Akt/eNOS Signalling Pathway.

Authors:  Yuehuan Wu; Cong Fu; Bing Li; Chang Liu; Zhi He; Xing-Er Li; Ailing Wang; Genshan Ma; Yuyu Yao
Journal:  J Diabetes Res       Date:  2021-09-11       Impact factor: 4.011

8.  The PI3K/Akt/mTOR pathway is implicated in the premature senescence of primary human endothelial cells exposed to chronic radiation.

Authors:  Ramesh Yentrapalli; Omid Azimzadeh; Arundhathi Sriharshan; Katharina Malinowsky; Juliane Merl; Andrzej Wojcik; Mats Harms-Ringdahl; Michael J Atkinson; Karl-Friedrich Becker; Siamak Haghdoost; Soile Tapio
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.